These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28531759)

  • 21. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.
    Sjöstrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
    J Immunol; 2013 Oct; 191(7):3753-63. PubMed ID: 23975864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of immunity and oncogenesis by the IRF transcription factor family.
    Savitsky D; Tamura T; Yanai H; Taniguchi T
    Cancer Immunol Immunother; 2010 Apr; 59(4):489-510. PubMed ID: 20049431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of organizational and expressional characterizations of the IFNs, IRFs and CRFBs in grass carp Ctenopharyngodon idella.
    Liao Z; Wan Q; Su J
    Dev Comp Immunol; 2016 Aug; 61():97-106. PubMed ID: 27012995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Interferon Regulatory Factors in Liver Diseases.
    Zeng C; Zhu X; Li H; Huang Z; Chen M
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-cancer analysis identifies the IRF family as a biomarker for survival prognosis and immunotherapy.
    Xu HG; Chen C; Chen LY; Pan S
    J Cell Mol Med; 2024 Feb; 28(3):e18084. PubMed ID: 38130025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene manipulation in the induction of anti-tumour immunity.
    O'Donnell D; Patel P; Reis e Sousa C
    Gene Ther; 1999 Nov; 6(11):1796-7. PubMed ID: 10602374
    [No Abstract]   [Full Text] [Related]  

  • 27. Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
    Zhang Y; Li H
    Physiology (Bethesda); 2017 May; 32(3):210-223. PubMed ID: 28404737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning and characterization of interferon regulatory factor 1 (IRF-1), IRF-2 and IRF-5 in the chondrostean paddlefish Polyodon spathula and their phylogenetic importance in the Osteichthyes.
    Xiaoni G; Zhuo C; Xuzhen W; Dengqiang W; Xinwen C
    Dev Comp Immunol; 2012 Jan; 36(1):74-84. PubMed ID: 21703300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.
    Kim R; Emi M; Tanabe K
    Immunology; 2006 Oct; 119(2):254-64. PubMed ID: 17005005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte-stromal cell interaction induces IL-7 expression by interferon regulatory factors.
    Sekai M; Tani-ichi S; Yoneyama M; Fujita T; Kina T; Ikuta K
    Mol Immunol; 2013 Jul; 54(3-4):378-85. PubMed ID: 23376291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC; Johnson PW; Glennie MJ
    Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.
    Honda K; Takaoka A; Taniguchi T
    Immunity; 2006 Sep; 25(3):349-60. PubMed ID: 16979567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon Regulatory Factor 4 Inhibits Neointima Formation by Engaging Krüppel-Like Factor 4 Signaling.
    Cheng WL; She ZG; Qin JJ; Guo JH; Gong FH; Zhang P; Fang C; Tian S; Zhu XY; Gong J; Wang ZH; Huang Z; Li H
    Circulation; 2017 Oct; 136(15):1412-1433. PubMed ID: 28851732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory dendritic cells in autoimmunity: A comprehensive review.
    Liu J; Cao X
    J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
    Szelag M; Piaszyk-Borychowska A; Plens-Galaska M; Wesoly J; Bluyssen HA
    Oncotarget; 2016 Jul; 7(30):48788-48812. PubMed ID: 27166190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases.
    Sigdel KR; Cheng A; Wang Y; Duan L; Zhang Y
    J Immunol Res; 2015; 2015():848790. PubMed ID: 26090502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of expression profile and prognostic significance of interferon regulatory factors in pancreatic cancer.
    Zhang K; Xu PL; Li YJ; Dong S; Gao HF; Chen LY; Chen H; Chen Z
    BMC Genom Data; 2022 Jan; 23(1):5. PubMed ID: 35012444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.